BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Okano H, Takashima K, Takahashi Y, Ojiro R, Tang Q, Ozawa S, Ogawa B, Koyanagi M, Maronpot RR, Yoshida T, Shibutani M. Ameliorating effect of continuous alpha-glycosyl isoquercitrin treatment starting from late gestation in a rat autism model induced by postnatal injection of lipopolysaccharides. Chem Biol Interact 2022;351:109767. [PMID: 34863679 DOI: 10.1016/j.cbi.2021.109767] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Owczarek-januszkiewicz A, Magiera A, Olszewska MA. Enzymatically Modified Isoquercitrin: Production, Metabolism, Bioavailability, Toxicity, Pharmacology, and Related Molecular Mechanisms. IJMS 2022;23:14784. [DOI: 10.3390/ijms232314784] [Reference Citation Analysis]
2 Okano H, Takashima K, Takahashi Y, Ojiro R, Tang Q, Ozawa S, Zou X, Koyanagi M, Maronpot RR, Yoshida T, Shibutani M. Progressive disruption of neurodevelopment by mid-gestation exposure to lipopolysaccharides and the ameliorating effect of continuous alpha-glycosyl isoquercitrin treatment. Environ Toxicol 2022. [PMID: 36125228 DOI: 10.1002/tox.23661] [Reference Citation Analysis]